secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2023-11-06T23:59:59+00:00
Accession:  0001801170-23-000103
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health Q3 Adjusted EBITDA loss narrows to $5.1M; raises 2023 guidance
----------------------------------------------------------------------------

- Revenue $482.1M; Insurance revenue up 12% YoY to $301.2M; Non-Insurance revenue down 70% to $176.0M.
- Insurance MCR improved to 78.5% from 86.3% YoY; year-to-date MCR 80.8%.
- Net loss of $41.5M; Adjusted EBITDA loss of $5.1M, vs. loss of $55.5M in Q3 2022.
- Full-year 2023 guidance: Insurance MCR 81%-82%, Adj. EBITDA ($55M)-($80M), improved from prior.
- CEO cites Clover Assistant, operational enhancements, and 3.5-star rating for margin improvement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117023000103/0001801170-23-000103-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117023000103/clov-20231106.htm
  HTML page:      https://secwatch.observer/filing/0001801170-23-000103

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer